ロード中...
BRAF-MEK inhibitors as steroid-sparing bridge prior to checkpoint blockade therapy in symptomatic intracranial melanoma
The introduction of immune checkpoint blockade (ICB) and BRAF-MEK inhibitors has substantially improved outcomes in patients with metastatic melanoma. However, several challenging factors may hinder the efficacy of ICB in patients with symptomatic intracranial metastatic melanoma who are immunosuppr...
保存先:
| 出版年: | Melanoma Manag |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Future Medicine Ltd
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8162174/ https://ncbi.nlm.nih.gov/pubmed/34084449 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/mmt-2020-0022 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|